GENE ONLINE|News &
Opinion
Blog

Asia-Pacific
Trials & Approvals Anti-PD-1
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Asia-Pacific Alpha Helices
Eisai Obtains Novel Anti-Cancer Molecules via PRISM BioLab Contract
2020-04-13
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
Anti-cancer
Samsung Biologics Inks CDO Contract with PharmAbcine to Develop Novel Drug
2020-04-08
COVID-19
Weekly Cover：Updates on COVID-19 in Asia
2020-04-08
Rare Disease
Daiichi Sankyo Invests in Ultragenyx’s Technology to Bolster Gene Therapy Pipeline
2020-04-02
Cancer
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
COVID-19 Japan
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
R&D Rare Disease
Mochida Pharma, Gene Techno Science Collaborate to Develop Regenerative Medicine for Rare Disease
2020-03-28
Trials & Approvals
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
R&D
Weekly Cover: Eisai to Launch “NouKNOWTM” in Japan for Regular Self-assessment of Brain Health
2020-03-26
Trials & Approvals Lung Cancer
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
COVID-19
Pharma Firm AnGes and Osaka University to Initiate Coronavirus Vaccine Testing on Animals
2020-03-25
Licensing PARP Inhibitor
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
1 … 26 27 28 29 30 … 35
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top